Navin Fluorine International Limited delivered exceptional financial performance in Q3FY26, with consolidated net profit surging 122% year-on-year to ₹185.40 crores compared to ₹83.60 crores in the corresponding quarter of the previous fiscal year. The specialty chemicals company's revenue from operations grew robustly by 47% to ₹892.37 crores from ₹606.20 crores in Q3FY25.

Strong Revenue Growth Drives Performance

The company's total revenue, including other income, reached ₹907.95 crores in Q3FY26, representing a 47% increase from ₹616.68 crores in Q3FY25. Sequential growth was also impressive, with revenue rising 17% from ₹776.63 crores in Q2FY26.

Business Segment Performance Highlights

All three business verticals demonstrated strong growth momentum during Q3FY26. The HPP (High Performance Products) segment recorded revenue of ₹412 crores with 35% year-on-year growth, driven by higher realizations and volumes in a constructive pricing environment for HFC.

The Specialty Chemicals segment achieved its highest ever quarterly performance with revenue of ₹354 crores, marking 60% year-on-year growth. The CDMO (Contract Development and Manufacturing Organization) segment continued its momentum with ₹127 crores revenue, up 61% year-on-year.

Management Commentary on Growth Strategy

During the earnings call held on February 09, 2026, Chairman Vishad Mafatlal highlighted the company's resilient performance amid evolving global dynamics. "Our growth has been made possible by the relentless dedication and tireless efforts of our teams. Through focused teamwork, strong R&D initiatives and the adoption of right technologies, we have been able to navigate diverse global scenarios," he stated.

Managing Director Nitin Kulkarni emphasized the company's diversification strategy: "This improvement has been driven by our focus to diversify our portfolio, expand our market presence, deepen strategic partnerships and enhance customer relationships. This approach has solidified our presence as a globally trusted provider of diverse fluorochemical solutions."

Key Operational Milestones

The company achieved significant operational milestones during Q3FY26. The cGMP-4 Phase-1 facility was successfully commissioned and commercial supplies commenced during the quarter. The AHF (Anhydrous Hydrogen Fluoride) project was also commissioned, with commercial supplies starting in Q4FY26.

Exceptional Items Impact Results

The company recognized exceptional charges of ₹20.47 crores during Q3FY26 related to the implementation of new labour codes. These charges stemmed from the reassessment of employee benefit obligations following the consolidation of multiple labour legislations into four unified Labour Codes, which became effective from November 21, 2025. Despite these one-time charges, the company maintained strong profitability.

Nine-Month Performance Highlights

For the nine-month period ended December 31, 2025, Navin Fluorine International demonstrated consistent growth momentum. Consolidated net profit increased 133% to ₹450.93 crores compared to ₹193.62 crores in the corresponding period of FY25.

Advanced Materials and Future Growth

CFO Anish Ganatra outlined the company's margin outlook during the earnings call, stating that investors should expect Navin to deliver approximately 30% EBITDA margins on an annualized basis, plus or minus 200 basis points. The company is also progressing on Advanced Materials projects to become part of the semiconductor and electronic value chain, supported by India's Semiconductor Mission 2.0.

Dividend Distribution and Capital Structure

During Q3FY26, the company paid an interim dividend of ₹6.50 per share (325%) on 5,12,39,124 equity shares of nominal value ₹2 each, totaling ₹33.31 crores for FY26. The paid-up equity share capital stood at ₹10.25 crores as of December 31, 2025, reflecting the impact of the Qualified Institutional Placement completed in Q2FY26.

Standalone Results Show Solid Performance

On a standalone basis, the company reported net profit of ₹105.87 crores in Q3FY26 compared to ₹65.24 crores in Q3FY25, marking a 62% year-on-year increase. Standalone revenue from operations grew 30% to ₹570.01 crores from ₹439.77 crores in the corresponding quarter last year.

The results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on February 9, 2026, with limited review conducted by statutory auditors Price Waterhouse Chartered Accountants LLP. The company has also released the transcript of its earnings call held on February 09, 2026, in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Navin Fluorine International Limited has scheduled an analyst and institutional investor meet for February 18, 2026, in compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company announced this development through a formal communication to BSE Limited and National Stock Exchange of India Limited on February 10, 2026.

Meeting Details and Compliance

The company officials will interact with analysts and investors on a group basis at 13:00 PM IST on February 18, 2026. The discussions will be based exclusively on publicly available information, with the company noting that changes may occur due to exigencies on the part of the host or company.

The presentation materials for the meeting have been prepared and enclosed with the regulatory filing. This information is also being made available on the company's website at www.nfil.in .

Strong Q3 FY26 Financial Performance

The company has demonstrated robust financial performance in Q3 FY26, with significant growth across key metrics. Sales reached Rs. 892.37 crores, marking a substantial 47% year-on-year growth and 18% quarter-on-quarter improvement.

Nine-Month FY26 Performance Highlights

For the nine-month period ending December 2025, the company achieved consolidated sales of Rs. 2,376.19 crores, representing 44% year-on-year growth. Operating EBITDA reached Rs. 760.53 crores with an impressive 114% year-on-year increase.

Business Segment Performance

All three business verticals demonstrated strong growth momentum during Q3 FY26. The HPP segment achieved 35% year-on-year revenue growth, while Specialty Chemicals recorded 60% growth and CDMO segment expanded by 61%.

Ongoing Capital Expenditure Projects

The company has outlined three major capex initiatives totaling approximately Rs. 431.50 crores. These include additional HFC capacity equivalent to 15,000 MTPA of R32 with an investment of Rs. 236.50 crores, MPP capacity de-bottlenecking at Dahej requiring Rs. 75.00 crores, and Advanced Materials manufacturing capacity with Rs. 120.00 crores investment.

The scheduled analyst meet will provide stakeholders with detailed insights into the company's strategic initiatives, financial performance, and growth outlook based on the strong momentum demonstrated across all business segments.